Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > FTSE 100 posts longest winning streak in more than 5 years, healthcare stocks boosts
    Finance

    FTSE 100 posts longest winning streak in more than 5 years, healthcare stocks boosts

    Published by Global Banking & Finance Review®

    Posted on April 28, 2025

    2 min read

    Last updated: January 24, 2026

    FTSE 100 posts longest winning streak in more than 5 years, healthcare stocks boosts - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    FTSE 100 records its longest winning streak since 2019, driven by healthcare stocks. Easing U.S.-China trade tensions bolster market sentiment.

    FTSE 100 Achieves Longest Winning Streak in 5 Years, Led by Healthcare

    (Reuters) -British equities ended higher on Monday with heavyweight healthcare companies leading gains in the benchmark index, while U.S. trade policy developments remained in focus.

    The blue-chip FTSE 100 was nearly flat but posted its 11th consecutive winning session. The index also posted its longest winning streak since December 2019.

    The midcap FTSE 250 gained 0.6%.

    Healthcare stocks gained 1.1%, with AstraZeneca and GSK boosting the highest gains in the FTSE 100, up 1.2% and 1.4% respectively.

    Market sentiment was supported by signs of easing U.S.-China trade tensions last week. However, uncertainties about the global trade war continued.

    Entain finished up 6.8%, after the British gambling firm's joint venture with MGM Resorts, BetMGM, swung to first-quarter profit in an e-betting surge.

    Deliveroo jumped 16.5%, leading the gains on the midcap index, after confirming on Friday that it had received a takeover proposal from U.S. peer DoorDash on April 5.

    On the data side, British retail sales volumes fell by the smallest amount since October this month but stores expect conditions to worsen next month, according to a survey that reflected concerns about growth and consumer confidence.

    Britain has proposed a broad statement of shared values with the European Union that emphasises support for Ukraine's territorial integrity, the Paris Climate Agreement and open and free trade, according to a draft document seen by Reuters.

    Although it does not mention the Trump administration by name, several elements of the text present a striking contrast to current U.S. policies.

    Separately, trade ministers of UK and India began two days of talks to conclude more than three years of negotiations on a trade pact, under additional pressure to reach a deal because of U.S. President Donald Trump's tariffs on exports to the U.S.

    (Reporting by Sanchayaita Roy and Ragini Mathur in Bengaluru; Editing by Varun H K, William Maclean)

    Key Takeaways

    • •FTSE 100 posts 11th consecutive winning session.
    • •Healthcare stocks, including AstraZeneca and GSK, lead gains.
    • •Easing U.S.-China trade tensions support market sentiment.
    • •Entain and Deliveroo see significant stock gains.
    • •UK-India trade talks continue amid global trade uncertainties.

    Frequently Asked Questions about FTSE 100 posts longest winning streak in more than 5 years, healthcare stocks boosts

    1What is the main topic?

    The main topic is the FTSE 100's longest winning streak in over five years, driven by gains in healthcare stocks.

    2What influenced the market sentiment?

    Market sentiment was influenced by easing U.S.-China trade tensions and strong performances by healthcare stocks.

    3Which companies led the FTSE 100 gains?

    AstraZeneca and GSK led the gains in the FTSE 100, with increases of 1.2% and 1.4% respectively.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostGreece to install train control systems by September in reform after deadly 2023 crash
    Next Finance PostOlympics-London mayor hopes city will bid for 2040 Olympics as part of ambitious hosting plan